Form 4: Compass Therapeutics Executive Buys Shares
Insider Transaction (Form 4)
Neil Lerner, Chief Accounting Officer of Compass Therapeutics, Inc., purchased 2,500 shares of common stock on September 24, 2026 for $1.14 per share.
Summary
- Open-market purchase: acquired 2,500 Common Stock at $1.14 ($2,850) on September 24, 2026; holds 400,000 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $2,850, committing personal capital to the stock.
Insider Transactions
Neil Lerner — Officer (Chief Accounting Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-24 | Open-market purchase | Common Stock | 2,500 | $1 | $2.9K | 400,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-24 | Open-market purchase (2,500 shares) |
Keywords
insider transaction, Form 4, CMPX, Compass Therapeutics, Inc., bullish, Neil Lerner
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.